Adial Pharmaceuticals, Inc. Stock Issued During Period, Shares, Conversion of Convertible Securities
Adial Pharmaceuticals, Inc. (ADIL) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 700.85 thousand shares for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-09-10.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2018-09-10
- 2018-06-30: Stock Issued During Period, Shares, Conversion of Convertible Securities 6 month 700.85K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 6 month |
|---|---|
| 2018-06-30 | 700.85K shares 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |